Medical Aesthetics Market Expected to Reach USD 40.5 Billion by 2035 as Non-Surgical Treatments Lead

[Los Angeles, 17th June 2025] – The global medical aesthetics market, valued at USD 15.2 billion in 2023, is projected to reach USD 40.5 billion by 2035, growing at a CAGR of 9.8%, according to Clearview Market Insights.

Request Sample @ https://clearviewmarketinsights.com/report-details/global-medical-aesthetics-market/

Key Drivers

  • "Tweakment" revolution: Non-surgical facelifts (e.g., HIFU) grow at 14% CAGR.
  • Male demand: 1 in 4 consumers now male, driven by body sculpting.
  • Tech integration: 40% of clinics use AI for personalized treatments.

Competitive Landscape

Allergan (AbbVie) leads with a 32% share, while startups like Lumenis disrupt the market with AI tools. Galderma’s Restylane Eyelight and Merz’s Samsung partnership underscore innovation.

Regional Trends

  • North America accounts for a 45% share, with the U.S. dominating the demand for Botox and fillers.
  • Asia-Pacific: South Korea’s K-beauty trends drive growth (12% CAGR).

Future Milestones

  • 2026: FDA approves first mRNA-based skin rejuvenation.
  • 2030: 60% of treatments use AI for real-time customization.

"The future is hyper-personalized, tech-driven aesthetics," says Dr. Emily Tran, CVMI Aesthetics Lead.

 

 

 

For more insights, visit https://clearviewmarketinsights.com/

 

About Clearview Market Insights:

Clearview Market Insights is a leading market research and consulting firm providing in-depth industry analysis and strategic recommendations for businesses worldwide.

 

Media contact:

Bhavani K

Marketing and Sales Head

ClearView Market Insights

Mail: sales@clearviewmarketinsights.com

Phone: +1 917-993-7369

Comments

Post a Comment

Popular posts from this blog

Global CNS Biomarker Market to Exceed USD 17.89 Billion by 2031, Fueled by Demand for Early Diagnosis and Precision Neurology

[Boston, 4 th July 2025] – Clearview Market Insights (CVMI) reports that the global CNS biomarker market will grow from USD 7.93 billion in 2024 to USD 17.89 billion by 2031, with a CAGR of 12.3%. The market is driven by the increasing prevalence of neurological disorders, rising demand for early diagnostics, and advances in precision medicine in neuroscience. “CNS biomarkers are transforming neurology by facilitating early diagnosis, personalized therapies, and efficient disease monitoring, especially in Alzheimer’s and Parkinson’s disease,” said Dr. Elena Foster, neuroscience analyst at CVMI. Request Sample @ https://clearviewmarketinsights.com/report-details/global-central-nervous-system-cns-biomarker-market/ Key Market Highlights 2024 Market Size: USD 7.93 billion 2031 Forecast: USD 17.89 billion CAGR: 12.3% (2024–2031) Growth Catalysts Rise in neurological disorders: Alzheimer's, Parkinson's, MS driving biomarker demand. Precision ...
Read more

Global Chemotherapy Chair Market to Reach USD 2.34 Billion by 2031, Driven by Growth in Outpatient Cancer Care and Technological Innovation

[Berlin, 3 rd July 2025 ] – Clearview Market Insights (CVMI) estimates that the global chemotherapy chair market will increase from USD 1.06 billion in 2024 to USD 2.34 billion by 2031, with a CAGR of 11.9%. The rising cancer burden and the shift toward ambulatory infusion centers are key growth drivers. “Modern chemotherapy chairs are evolving beyond basic seating—they are integrated with patient comfort features, smart controls, and infection-resistant materials, transforming cancer care delivery,” said Dr. Maxine Schultz, oncology infrastructure analyst at CVMI. Request Sample @ https://clearviewmarketinsights.com/report-details/global-chemotherapy-chair-market/   Key Market Highlights 2024 Market Size: USD 1.06 billion 2031 Forecast: USD 2.34 billion CAGR: 11.9% (2024–2031) Growth Catalysts Outpatient and Home-Based Chemotherapy Growth: Increasing Need for Portable and Comfortable Infusion Chairs Patient-Centric Healthcare:...
Read more

Europe Veterinary Equipment and Disposables Market to Reach USD 1.47 Billion by 2032, Fueled by Rising Pet Healthcare Demand and Technological Advancements

[Hyderabad, July 1, 2025] – The Europe Veterinary Equipment and Disposables Market is expected to reach USD 1.47 billion by 2032 , growing at a CAGR of 6.2% from 2024 to 2032, according to recent market intelligence. This growth is being driven by the increasing pet population, advancements in veterinary healthcare technology, and growing investments in animal wellness infrastructure across the continent. Request Sample @ https://clearviewmarketinsights.com/report-details/europe-veterinary-equipment-and-disposables-market/ Key Growth Catalysts The European region is witnessing a surge in pet adoption , with a sharp rise in the number of companion animals, especially cats and dogs. This trend is coupled with increased awareness among pet owners regarding preventive and therapeutic veterinary care. Governments and regulatory bodies in countries such as Germany, France, and the UK are actively promoting animal welfare policies, which in turn are pushing demand for high-quality ...
Read more